2m 2m 2m 2m 2m 2m 2m
Vericel (VCEL)
NASDAQ
$40.40+$0.010 (+0.02%)
Price as of Jun 23, 2026 4:10 PM EDT- $2.1BMarket Cap
- -6.81%1-Year Change
- BiotechnologyIndustry
Vericel (VCEL)
$40.40+$0.010 (+0.02%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 276.3M +16.45% | 237.2M +20.10% | 197.5M +20.17% | 164.4M +5.24% | |
Cost of Revenue | 70.7M +8.51% | 65.1M +5.13% | 61.9M +13.49% | 54.6M +8.81% | |
Gross Profit | 205.6M +19.46% | 172.1M +26.95% | 135.6M +23.49% | 109.8M +3.55% | |
Sales and Marketing Expense | 167.0M +16.95% | 142.8M +18.01% | 121.0M +13.18% | 106.9M +9.54% | |
Research and Development Expense | -27.6M +11.15% | -24.8M +17.85% | -21.0M +5.51% | -19.9M +22.45% | |
Depreciation and Amortization Expense | 11.5M +109.74% | 5.5M +18.83% | 4.6M +16.35% | 4.0M +34.27% | |
Total Operating Expenses | 194.6M +16.09% | 167.6M +17.99% | 142.0M +11.98% | 126.8M +11.39% | |
Operating Profit | 11.0M +144.39% | 4.5M +169.91% | -6.5M -62.11% | -17.1M +117.19% | |
Interest Income | 7.0M +9.31% | 6.4M +38.39% | 4.6M +245.41% | 1.3M +498.66% | |
Interest Expense | N/A N/A | N/A N/A | -600,000 +63.93% | -366,000 +9,050.00% | |
Interest Income and Expense and Net | 7.0M +9.31% | 6.4M +58.98% | 4.0M +313.54% | 975,000 +343.18% | |
Total Nonoperating Income and Expense | 6.3M +5.71% | 6.0M +46.26% | 4.1M +282.80% | 1.1M +293.38% | |
Income before Taxes | 17.4M +65.34% | 10.5M +543.83% | -2.4M -85.19% | -16.0M +110.87% | |
Income Taxes | 859,000 +480.41% | 148,000 -81.82% | 814,000 +12.90% | 721,000 +749.55% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | 16.5M +59.41% | 10.4M +425.64% | -3.2M -80.96% | -16.7M +123.65% | |
Net Income from Continuing Operations Applicable to Common | 17.4M +65.34% | 10.5M +543.83% | -2.4M -85.19% | -16.0M +110.87% | |
Basic EPS and Net Income | 0.33 +57.14% | 0.21 +400.00% | -0.07 -80.00% | -0.35 +118.75% | |
Diluted EPS and Net Income | 0.32 +60.00% | 0.20 +385.71% | -0.07 -80.00% | -0.35 +118.75% | |
Basic Weighted Average Shares | 50.3M +3.05% | 48.8M +2.64% | 47.6M +0.98% | 47.1M +1.42% | |
Diluted Weighted Average Shares | 52.2M +0.91% | 51.7M +8.59% | 47.6M +0.98% | 47.1M +1.42% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 100.1M +34.32% | 74.5M +7.86% | 69.1M +35.29% | 51.1M -25.26% | |
Short-Term Investments | 37.4M -10.28% | 41.7M +3.02% | 40.5M -40.90% | 68.5M +95.25% | |
Cash and Cash Equivalents and Short-Term Investments | 137.5M +18.32% | 116.2M +6.08% | 109.6M -8.35% | 119.5M +15.61% | |
Total Current Assets | 247.4M +16.29% | 212.8M +3.48% | 205.6M +10.04% | 186.9M +17.92% | |
Accumulated Depreciation | 31.6M +17.29% | 26.9M +21.13% | 22.2M +21.33% | 18.3M +27.79% | |
Property and Plant and Equipment and Net | 108.4M +5.08% | 103.2M +147.77% | 41.6M +162.90% | 15.8M +19.00% | |
Total Long-Term Assets | 341,000 -38.67% | 556,000 -27.89% | 771,000 -40.83% | 1.3M +311.04% | |
Total Assets | 488.0M +12.77% | 432.7M +22.36% | 353.7M +29.54% | 273.0M +12.02% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Current Liabilities | 49.1M -2.26% | 50.3M +9.92% | 45.7M +22.12% | 37.5M +43.80% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 1.9M +116.44% | 876,000 +776.00% | 100,000 N/A | 0 -100.00% | |
Total Liabilities | 133.3M -5.28% | 140.8M +10.22% | 127.7M +58.19% | 80.7M +10.22% | |
Retained Earnings | -376.3M -4.21% | -392.8M -2.57% | -403.2M +0.80% | -400.0M +4.36% | |
Total Stockholders Equity | 354.6M +21.47% | 292.0M +29.22% | 226.0M +17.52% | 192.3M +12.79% | |
Total Shares Outstanding | 50.6M +2.00% | 49.6M +3.76% | 47.8M +1.22% | 47.3M +0.80% | |
Cash Flow | |||||
Cash from Operating Activities | 51.9M -10.75% | 58.2M +64.72% | 35.3M +99.64% | 17.7M -39.09% | |
Capital Expenditures | 27.2M -57.54% | 64.0M +219.66% | 20.0M +163.47% | 7.6M -4.03% | |
Cash from Investing Activities | -43.9M -44.41% | -79.0M +2,425.05% | -3.1M -91.36% | -36.2M +934.16% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 7.1M -62.89% | 19.1M +426.64% | 3.6M +246.22% | 1.0M -88.61% | |
Financials Ratio | |||||
Gross Margin | 74.42% +2.58% | 72.55% +5.70% | 68.64% +2.76% | 66.80% -1.60% | |
Operating Margin | 4.00% +109.85% | 1.91% +158.21% | -3.27% -68.47% | -10.38% +106.38% | |
Return on Assets | 3.59% +36.15% | 2.64% +359.52% | -1.02% -84.30% | -6.47% +94.48% | |
Return on Equity | 5.11% +27.68% | 4.00% +362.96% | -1.52% -83.48% | -9.21% +87.88% | |
Revenue Growth | 16.45% -18.15% | 20.10% -0.32% | 20.17% +285.05% | 5.24% -79.68% | |
Current Ratio | 5.03 +18.98% | 4.23 -5.86% | 4.49 -9.89% | 4.99 -17.99% | |
Cash Ratio | 2.04 +37.42% | 1.48 -1.87% | 1.51 +10.79% | 1.36 -48.03% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow